Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus
Open Access
- 23 November 2001
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 1 (1), 20
- https://doi.org/10.1186/1471-2407-1-20
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancerBritish Journal of Surgery, 2001
- Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity?The Japanese Journal of Thoracic and Cardiovascular Surgery, 1999
- Multimodal therapy for squamous carcinoma of the oesophagusBritish Journal of Surgery, 1999
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerThe New England Journal of Medicine, 1998
- Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trialThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Pattern of recurrence after oesophageal resection for cancer: Clinical implicationsBritish Journal of Surgery, 1996
- Downstaging of Esophageal Cancer After Preoperative Radiation and ChemotherapyAnnals of Surgery, 1995
- Recurrence pattern of oesophageal carcinoma after limited resection does not support wide local excision with extensive lymph node dissectionBritish Journal of Surgery, 1994
- Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagusBritish Journal of Surgery, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958